Preparation method of inactivated newcastle disease vaccine
A technology for chicken Newcastle disease and Newcastle disease, applied in the field of preparation of inactivated chicken Newcastle disease vaccine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0028] Embodiment 1: the preparation of inactivated chicken Newcastle disease vaccine
[0029] (a) Virus liquid inactivation:
[0030] (a1) Preparation of virus liquid: Dilute the Newcastle disease seed virus, shake well, inoculate SPF chicken embryos in the allantoic cavity of an automatic inoculation machine, inoculate 0.1ml per embryo, continue incubation in a 37°C incubator, and harvest dead embryos for 48-120 hours And 120 hours later, the allantoic fluid of live embryos was stored in a sterile container, and stored at -20°C after sampling;
[0031] (a2) Inactivation: thaw the frozen embryo fluid, inactivate after clarification and filtration, and directly inactivate the embryo fluid that has not been frozen. Mix, the final concentration of the formaldehyde solution is 0.2%, and then inactivate at 37°C for 24-26 hours (start timing when it is placed in the greenhouse), and shake 5-6 times during the period;
[0032] (a3) Blocking inactivation: add filter-sterilized 50% ...
Embodiment 2
[0040] Test items standard regulation test result Exterior Milky white slightly yellow emulsion Milky white slightly yellow emulsion dosage form water in oil type water in oil type viscosity meets the requirments Compliance stability Draw 10ml of the vaccine into the centrifuge tube, centrifuge at 3000r / min for 15 minutes, the water precipitated at the bottom of the tube should not exceed 0.5ml Anhydrous phase precipitation
[0041] A. Safety inspection
[0042] Use 6 SPF chickens aged 30-60 days, inject 1.0ml of vaccine subcutaneously in each muscle or neck and back, and observe for 14 days. There should be no local or systemic adverse reactions caused by the vaccine.
[0043] Test results: There were no local or systemic adverse reactions caused by the vaccine.
[0044] B. Efficacy test: test by serological method, if the result does not meet the requirements, it can be tested by immune challenge method.
[0045] (1) Sero...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com